Patents by Inventor Raffaella Scorza

Raffaella Scorza has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10028929
    Abstract: The subject of the present invention is the use of aminaphtone for the preparation of a medicament for treating arteriophaties, in particular arteriophaties of a degenerative inflammatory type. Preferably, said medicament is formulated for oral administration.
    Type: Grant
    Filed: January 13, 2011
    Date of Patent: July 24, 2018
    Assignee: LABORATORI BALDACCI S.P.A.
    Inventor: Raffaella Scorza
  • Publication number: 20140080154
    Abstract: The invention relates to a method for the identification of patients affected by Systemic Sclerosis (SSc) (early, limited cutaneous, diffuse forms) or Systemic Lupus Erythematosus (SLE). Among SSc and SLE patients, this method allows identification of presence of vascular ulcerations in SSc, and Raynaud's phenomenon in SLE, respectively.
    Type: Application
    Filed: April 13, 2012
    Publication date: March 20, 2014
    Applicant: VIVABIOCELL S.P.A.
    Inventors: Francesco Curcio, Giacomo Cattaruzzi, Massimo Moretti, Francesco Vitrani, Raffaella Scorza
  • Patent number: 8202903
    Abstract: The subject of the present invention is the use of aminaphtone for the preparation of a medicament for treating arteriophaties, in particular arteriophaties of a degenerative inflammatory type. Preferably, said medicament is formulated for oral administration.
    Type: Grant
    Filed: April 10, 2007
    Date of Patent: June 19, 2012
    Assignee: Fondazione IRCCS “CA' Granda—Ospedale Maggiore Policlinico”
    Inventor: Raffaella Scorza
  • Publication number: 20120022155
    Abstract: The subject of the present invention is the use of aminaphtone for the preparation of a medicament for treating arteriophaties, in particular arteriophaties of a degenerative inflammatory type.
    Type: Application
    Filed: January 13, 2011
    Publication date: January 26, 2012
    Applicant: FONDAZIONE IRCCS "CA' GRANDA-OSPEDALE MAGGIORE POLICLINICO"
    Inventor: Raffaella SCORZA
  • Publication number: 20090182045
    Abstract: The subject of the present invention is the use of aminaphtone for the preparation of a medicament for treating arteriophaties, in particular arteriophaties of a degenerative inflammatory type. Preferably, said medicament is formulated for oral administration.
    Type: Application
    Filed: April 10, 2007
    Publication date: July 16, 2009
    Applicant: FONDAZIONE IRCCS ISTITUTO DI RICOVERO E CURA A CARATTERE SCIENTIFICO DI NATURA
    Inventor: Raffaella Scorza